Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Cancer Discovery
|
October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Maria Rusan, Kapsok Li, Yvonne Li, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Communications
|
April 8, 2017
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Cancer Cell
|
May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
Wendy Béguelin, Relja Popovic, Matt Teater, et al.
Nature Communications
|
June 10, 2017
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Cancer Research
|
February 3, 2016
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Genes & Development
|
March 5, 2014
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
Esra A Akbay, Javid Moslehi, Camilla L Christensen, et al.
Nature Communications
|
April 1, 2026
Global hotspots of particulate organic carbon losses under climate change
Siyi Sun, M Francesca Cotrufo, R A Viscarra Rossel, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Cancer Discovery
|
October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Maria Rusan, Kapsok Li, Yvonne Li, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Communications
|
April 8, 2017
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Cancer Cell
|
May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
Wendy Béguelin, Relja Popovic, Matt Teater, et al.
Nature Communications
|
June 10, 2017
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Cancer Research
|
February 3, 2016
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Shohei Koyama, Esra A Akbay, Yvonne Y Li, et al.
Genes & Development
|
March 5, 2014
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
Esra A Akbay, Javid Moslehi, Camilla L Christensen, et al.
Nature Communications
|
April 1, 2026
Global hotspots of particulate organic carbon losses under climate change
Siyi Sun, M Francesca Cotrufo, R A Viscarra Rossel, et al.
Page
of 5